Enzymes

1. Introduction to Enzymes as Biocatalysts

An enzyme is a highly specialised biological catalyst that accelerates the rate of chemical reactions without itself undergoing any permanent chemical alteration in the overall process. Virtually every metabolic reaction within living systems is mediated by enzymes. These macromolecular catalysts exhibit several fundamental properties that make them unique:

• Proteinaceous and Non-Proteinaceous Nature: While the vast majority of enzymes are proteins, certain catalytic RNA molecules, termed ribozymes, also possess enzymatic activity.
• Exceptional Specificity: Enzymes display an extraordinary degree of specificity towards their substrates, distinguishing between closely related stereoisomers and structural analogues.
• Immense Catalytic Power: Enzymes can accelerate reaction rates by factors of $10^6$ to $10^{14}$ compared to their uncatalysed counterparts.
• Conservation of Thermodynamic Equilibrium: Enzymes only accelerate the rate at which chemical equilibrium is achieved; they do not alter the equilibrium constant ($K_{\text{eq}}$) or the overall free energy change ($\Delta G$) of a biochemical reaction.

Simple versus Conjugated Enzymes

Proteinaceous enzymes are divided into two general classes based on their chemical composition:

• Simple Enzymes: Composed entirely of polypeptide chains of amino acids, requiring no additional chemical components for catalytic activity (e.g., ribonuclease A, trypsin).
• Conjugated Enzymes: Require non-protein chemical components, termed cofactors, for functional activity.

A conjugated enzyme without its cofactor is catalytically inactive and is referred to as an apoenzyme. When the apoenzyme binds its specific cofactor, the complete, catalytically active complex is formed, which is termed a holoenzyme:

$$ \text{Apoenzyme (Inactive Protein)} + \text{Cofactor (Non-Protein Component)} \rightleftharpoons \text{Holoenzyme (Active Complex)} $$

                                  +-------------------+
                                  |      ENZYME       |
                                  +---------+---------+
                                            |
                    +-----------------------+-----------------------+
                    |                                               |
          +---------+---------+                           +---------+---------+
          | Proteinaceous     |                           | Non-Proteinaceous |
          | (Protein-based)   |                           | (RNA-based)       |
          +---------+---------+                           +---------+---------+
                    |                                               |
          +---------+---------+                           +---------+---------+
          |      Enzyme       |                           |     Ribozyme      |
          +---------+---------+                           +-------------------+
                    |
          +---------+-----------------------+
          |                                 |
+---------+---------+             +---------+---------+
|   Simple Enzyme   |             | Conjugated Enzyme |
| (Amino acids only)|             |   (Holoenzyme)    |
+-------------------+             +---------+---------+
                                            |
                    +-----------------------+-----------------------+
                    |                                               |
          +---------+---------+                           +---------+---------+
          |  Apoenzyme (Inert)|                           | Cofactor (Active) |
          +-------------------+                           +---------+---------+
                                                                    |
                    +-----------------------------------------------+-------------------------------+
                    |                                                                               |
          +---------+---------+                                                           +---------+---------+
          |     Metal Ion     |                                                           |     Coenzyme      |
          |    (Inorganic)    |                                                           | (Organic Complex) |
          +---------+---------+                                                           +---------+---------+
                    |                                                                               |
          +---------+---------+                                         +---------------------------+---------------------------+
          |                   |                                         |                                                       |
+---------+---------+ +-------+---------+                             +---------+---------+                                   +---------+---------+
| Metal-Activated   | | Metalloenzyme   |                             | Prosthetic Group  |                                   |   Cosubstrate     |
| (Weakly bound)    | | (Tightly bound) |                             | (Covalently bound)|                                   | (Loosely bound)   |
+-------------------+ +-----------------+                             +-------------------+                                   +-------------------+

Cofactor Taxonomy

Cofactors are classified into two broad chemical divisions:

1. Inorganic Metal Ions:
   • Metal-Activated Enzymes: Bind metal ions weakly and reversibly during catalysis (e.g., $\text{Mg}^{2+}$, $\text{K}^+$).
   • Metalloenzymes: Contain tightly bound metal ions that are essential for maintaining the stable native conformation and facilitating catalysis (e.g., $\text{Fe}^{2+}/\text{Fe}^{3+}$ in cytochromes, $\text{Zn}^{2+}$ in carbonic anhydrase).
2. Organic Coenzymes: Complex organic or metallo-organic molecules, many of which are derived from water-soluble vitamins. Coenzymes are further classified based on their association with the apoenzyme:
   • Cosubstrates: Transiently and weakly associated with the enzyme molecule, binding and dissociating during each catalytic cycle (e.g., $\text{NAD}^+$, $\text{NADP}^+$). They act as carrier molecules that are chemically altered during the reaction and must be regenerated in subsequent reactions.
   • Prosthetic Groups: Covalently or extremely tightly associated with the protein matrix, remaining bound throughout the entire catalytic sequence (e.g., heme, biotin, flavin adenine dinucleotide – $\text{FAD}$).

Water-Soluble Vitamins and Their Coenzyme Forms

Water-soluble B-complex vitamins serve as essential dietary precursors for the synthesis of key coenzymes that participate in diverse metabolic pathways:

The vitamins in the human diet that are coenzyme precursors are all water-soluble vitamins.

2. Naming and Classification of Enzymes (EC System)

Historically, enzymes were assigned trivial names based on their source (e.g., trypsin, pepsin) or substrate plus the suffix -ase (e.g., urease). To resolve naming ambiguities, the International Union of Biochemistry (now IUBMB) established a systematic numerical classification scheme in 1961.

The Enzyme Commission (EC) Number Scheme

Every enzyme is assigned a unique four-digit EC Number of the form EC A.B.C.D:

• A (First Digit): The major class, indicating the general type of reaction catalysed.
• B (Second Digit): The subclass, specifying the group or chemical bond affected (e.g., donor group type in redox reactions, chemical group transferred).
• C (Third Digit): The sub-subclass, indicating the specific co-substrate or acceptor group (e.g., electron acceptor, functional group acceptor).
• D (Fourth Digit): The serial number, identifying the specific enzyme within its sub-subclass.

For example, the systematic classification of Hexokinase (EC 2.7.1.1) is designated as follows:

• Class 2 (Transferases): Transfer of a functional group between molecules.
• Subclass 7 (Phosphotransferases): Transfer of a phosphorus-containing group.
• Sub-subclass 1 (Alcohol acceptor): Hydroxyl group of a hexose acts as the phosphate acceptor.
• Serial Number 1: Hexokinase.

The systematic name of an enzyme consists of two parts: the name of the substrate(s) followed by a word ending in -ase that indicates the nature of the reaction (e.g., L-malate:$\text{NAD}^+$ oxidoreductase for malate dehydrogenase).

The Seven Major Enzyme Classes

Enzymes are systematically divided into seven distinct classes based on the nature of the chemical reactions they catalyse:

               +-------------------------------------------------------+
               |                    ENZYME CLASSES                     |
               +---------------------------+---------------------------+
                                           |
     +-----------------+-------------------+-----------------+-----------------+
     |                 |                   |                 |                 |
+----+----+       +----+----+         +----+----+       +----+----+       +----+----+
|   EC 1  |       |   EC 2  |         |   EC 3  |       |   EC 4  |       |   EC 5  |
|  Oxido- |       | Trans-  |         | Hydro-  |       |  Lyases |       | Isomer- |
| reduct- |       | ferases |         |  lases  |       |         |       |  ases   |
|  ases   |       +---------+         +---------+       +---------+       +---------+
+---------+            |                   |                 |                 |
     |        +--------+--------+     +----+----+       +----+----+       +----+----+
     |        | EC 6   | EC 7   |     |   EC 6  |       |   EC 7  |       |   EC 5  |
     |        | Ligases| Trans- |     | Ligases |       | Trans-  |       | Isomer- |
     |        |        | locases|     |         |       | locases |       |  ases   |
     |        +--------+--------+     +---------+       +---------+       +---------+
     |
     +-------------------------------------------------------------------------+

• EC 1: Oxidoreductases

  Catalyse oxidation-reduction reactions where electrons or hydrogen atoms are transferred from a donor (reductant) to an acceptor (oxidant):

  $$ \text{A}_{\text{red}} + \text{B}_{\text{ox}} \rightleftharpoons \text{A}_{\text{ox}} + \text{B}_{\text{red}} $$

  Subclasses include:

  • Dehydrogenases: Transfer hydrogen atoms to an electron acceptor other than oxygen (e.g., $\text{NAD}^+$).
  • Oxidases: Use molecular oxygen ($\text{O}_2$) as an electron acceptor, but oxygen atoms are not incorporated into the product.
  • Oxygenases: Incorporate one or both oxygen atoms from $\text{O}_2$ directly into the product (divided into monooxygenases/mixed-function oxidases and dioxygenases).
  • Peroxidases: Use hydrogen peroxide ($\text{H}_2\text{O}_2$) as an electron acceptor.
• EC 2: Transferases

  Catalyse the transfer of a functional group (e.g., methyl, acyl, phosphate, amino) from one molecule (donor) to another (acceptor):

  $$ \text{A-B} + \text{C} \rightleftharpoons \text{A} + \text{B-C} $$

• EC 3: Hydrolases

  Catalyse the hydrolytic cleavage of covalent bonds (e.g., C-O, C-N, C-C, P-O) by introducing a water molecule:

  $$ \text{A-B} + \text{H}_2\text{O} \rightleftharpoons \text{A-H} + \text{B-OH} $$

• EC 4: Lyases

  Catalyse the non-hydrolytic cleavage of chemical bonds (C-C, C-O, C-N, C-S), often resulting in the formation of a double bond, or catalyse the addition of groups to double bonds:

  $$ \text{A-B} \rightleftharpoons \text{A} + \text{B} \quad \text{or} \quad \text{A=B} + \text{H-X} \rightleftharpoons \text{A(H)-B(X)} $$

• EC 5: Isomerases

  Catalyse geometric or structural rearrangements within a single molecule (e.g., epimerisations, racemisations, cis-trans isomerisations, mutase-catalysed transfers):

  $$ \text{A-B} \rightleftharpoons \text{B-A} $$

• EC 6: Ligases

  Catalyse synthetic condensation reactions joining two molecules together, coupled with the hydrolytic cleavage of a high-energy phosphate bond in a nucleoside triphosphate (ATP, GTP, etc.):

  $$ \text{A} + \text{B} + \text{ATP} \rightleftharpoons \text{A-B} + \text{ADP} + \text{P}_{\text{i}} $$
  Note: ‘Ligase’ is the recommended name for ‘synthetase’.

• EC 7: Translocases

  Catalyse the active transport of ions or molecules across biological membranes, or their transfer from one side of a membrane to the other (“side 1” to “side 2”).

Distinction Between Synthases and Synthetases

Biochemical nomenclature maintains a strict functional distinction between these terms:

• Synthase: An enzyme belonging to the Lyase (EC 4) or other non-ligase classes. It catalyses condensation or addition reactions that do not require the hydrolysis of a nucleoside triphosphate (e.g., citrate synthase, glycogen synthase).
• Synthetase: An enzyme belonging to the Ligase (EC 6) class. It catalyses condensation reactions that are directly coupled to and require the energy released by nucleoside triphosphate hydrolysis (e.g., glutamine synthetase, aminoacyl-tRNA synthetase).

Meaning of EC Number (Example Breakdown)

The first digit of an EC number represents the major class. For class 1 (Oxidoreductases), the second digit (subclass) indicates the donor of reducing equivalents (hydrogen or electrons), and the third digit (sub-subclass) refers to the hydrogen or electron acceptor:

• EC 1 (Oxidoreductases):
  • Second digit (Subclass):
    • Alcohol ($-\text{CH-OH}$) group donor
    • Aldehyde or ketone ($-\text{C=O}$) group donor
    • Primary amine ($-\text{CH-NH}_2$) group donor
    • Secondary amine ($-\text{CH-NH-}$) group donor
  • Third digit (Sub-subclass):
    • $\text{NAD}^+$ or $\text{NADP}^+$ acceptor
    • $\text{Fe}^{3+}$ acceptor
    • $\text{O}_2$ acceptor

Similarly, the first digit for EC 5 indicates Isomerases. For class 5:

• Second digit (Subclass):
  • Racemisation or epimerisation
  • Cis-trans isomerisation
• Third digit (Sub-subclass):
  • Amino acids substrate
  • Hydroxy acids substrate

3. The Biophysics of Enzyme Action and Transition State Theory

Every chemical reaction has a specific energy barrier that reactants must overcome before transitioning into products.

Thermodynamic Stability and Activation Energy

The change in Gibbs free energy ($\Delta G$) of a reaction defines the thermodynamic feasibility and direction of the process:

• Exergonic Reactions ($\Delta G < 0$): Spontaneous, releasing free energy.
• Endergonic Reactions ($\Delta G > 0$): Non-spontaneous, requiring an input of free energy.

Crucially, $\Delta G$ is independent of the reaction rate. A reaction can be highly exergonic (thermodynamically favoured) yet proceed at an imperceptibly slow rate due to a high activation energy barrier.

The transition state ($\text{S}^\ddagger$) represents the transient, unstable configuration of highest free energy along the reaction coordinate, where reactant chemical bonds are maximally strained and partially formed/broken:

        Free Energy (G)
          ^
          |      [S‡] (Transition State)
          |       _|_
          |      /   \  <-- Activation Energy (uncatalysed) (ΔG‡uncat)
          |     /     \
          |    /   _ _ \ <-- Activation Energy (catalysed) (ΔG‡cat)
          |   /   /     \
          |  /   /       \
          | [S] /         \
          |----/           \
          |                 \

| \______ [P] (Product)
| :--- |
|  | <------ Free Energy Change of Reaction (ΔG remains unchanged)

          +---------------------------------------------------------> Reaction Coordinate

The difference in free energy between the ground state of the substrate and the transition state is called the Gibbs free energy of activation ($\Delta G^\ddagger$):

• A higher $\Delta G^\ddagger$ restricts the number of molecules with sufficient kinetic energy to reach the transition state, resulting in a slower reaction rate.
• Enzymes accelerate reaction rates by lowering the activation energy barrier ($\Delta G^\ddagger_{\text{cat}} < \Delta G^\ddagger_{\text{uncat}}$).
• They do not alter the free energy levels of the substrate ($\text{S}$) or product ($\text{P}$), meaning the overall $\Delta G$ and equilibrium position remain completely unchanged.

The Active Site and Weak Non-Covalent Interactions

Catalysis occurs within a specialised pocket of the enzyme known as the active site. The active site consists of two functionally distinct but spatially integrated regions:

• Binding Site: Aligns and anchors the substrate molecule in the correct spatial orientation.
• Catalytic Site: Contains the specific amino acid residues (catalytic groups) that participate in bond-cleaving and bond-forming reactions.

Substrate binding to the active site is mediated by a combination of weak, reversible, non-covalent interactions:

• Hydrogen bonding (highly directional, establishing specificity).
• Hydrophobic interactions (entropic driving force excluding water molecules).
• Ionic/Electrostatic interactions (attraction between opposite charges).
• Reversible covalent bonds (in certain transition states).

The Biophysical Concept of Binding Energy

The primary source of energy used by enzymes to lower activation energy is binding energy ($\Delta G_{\text{B}}$). Binding energy is the free energy released during the formation of numerous weak, non-covalent interactions between the enzyme and the substrate:

• The active site of an enzyme is not perfectly complementary to the substrate in its ground state. If it were, the enzyme-substrate complex would fall into a deep thermodynamic well, increasing the activation energy required to reach the transition state.
• Instead, the active site is complementary to the transition state of the reaction.
• The maximum release of binding energy occurs when the substrate is strained and distorted into the transition state conformation. This energy of interaction physically offsets the thermodynamic penalty of bond distortion, effectively lowering the activation barrier.

Lock-and-Key versus Induced-Fit Models

To describe the physical nature of substrate binding, two primary models have been developed:

• The Lock-and-Key Model (Emil Fischer, 1894): Proposes that the active site of the free, unbound enzyme is a rigid, pre-formed template that is perfectly complementary to the shape of the substrate.
• The Induced-Fit Model (Daniel Koshland, 1958): Proposes that enzymes are flexible, dynamic macromolecules. The active site of the free enzyme is not initially complementary to the substrate. The binding of the substrate induces a conformational change in the enzyme, reshaping the active site to form a complementary fit around the substrate in its transition state:

   A. Lock-and-Key Model:
      +-----+     +---+        +---------+        +---+   +---+
      |  _  |     |   |        |  _ _ _  |        |   |   |   |
      | / \ |  +  |   |  ===>  | / \_/ \ |  ===>  |   | + |   |
      +-----+     +---+        +---------+        +---+   +---+
      Enzyme     Substrate      ES Complex       Enzyme   Products
   B. Induced-Fit Model:
      +-----+     +---+        +---------+        +-----+   +---+   +---+
      |     |     |   |        |  _ _ _  |        |     |   |   |   |   |
      | \_/ |  +  |   |  ===>  | / \_/ \ |  ===>  | \_/ | + |   |   |   |
      +-----+     +---+        +---------+        +-----+   +---+   +---+
      Enzyme     Substrate      ES Complex        Enzyme   Products
      (Unbound,                (Conformational    (Returned to
       flexible)                change induced)    original shape)

4. Mechanistic Catalytic Strategies

Enzymes employ specific chemical and physical strategies within the active site to facilitate the conversion of substrates into products:

Covalent Catalysis

Covalent catalysis involves the formation of a transient, reversible covalent bond between the substrate and a nucleophilic group on the enzyme. This divides the reaction pathway into two distinct steps, replacing a single high-activation-energy barrier with two lower-activation-energy steps.

• Nucleophiles (Electron-rich donors): Amino acid side chains containing oxygen, nitrogen, or sulfur (e.g., the hydroxyl group of serine, the imidazole ring of histidine, the thiolate of cysteine, or the carboxylate of aspartate/glutamate) act as nucleophiles, attacking electrophilic centres on the substrate. Typical nucleophiles include negatively charged oxygen, negatively charged sulfhydryl, carbanions, and imidazole groups.
• Electrophiles (Electron-deficient centres): Carbonyl carbons, phosphoryl groups, and glycosyl groups act as electrophilic targets.
• Coenzyme Adducts: Some coenzymes (such as thiamine pyrophosphate or pyridoxal phosphate) can form covalent adducts with substrates, generating highly reactive intermediates (e.g., carbanions or Schiff bases) that act as electrophilic centres.

Acid-Base Catalysis

Acid-base catalysis involves the transfer of protons ($\text{H}^+$) during the transition state. It is divided into two mechanistic types:

• Specific Acid-Base Catalysis: Involves the direct participation of hydronium ($\text{H}_3\text{O}^+$) or hydroxide ($\text{OH}^-$) ions from the bulk solvent. The rate of the reaction is determined solely by the pH of the solution; changes in buffer concentration at a constant pH have no effect on the reaction rate.
• General Acid-Base Catalysis: Involves proton transfer mediated by weak organic acids or bases that act as proton donors or acceptors. In the active site, amino acid side chains (e.g., imidazole of histidine, carboxyl of aspartate/glutamate, hydroxyl, amino, or phenolic groups) act as general acids or bases, donating or accepting protons to stabilise charges on the transition state. The rate of the reaction is influenced by the concentration of the buffering species that can donate or accept protons, whereas pH has no independent effect in pure general acid-base catalysis.

Metal Ion Catalysis

Approximately one-third of all known enzymes require metal ions for catalytic activity. Metal ions facilitate reactions through several mechanisms:

• Orientation and Binding: Coordinate bonds hold the substrate in the optimal orientation for nucleophilic attack.
• Electrophilic Catalysis: Metal ions act as Lewis acids (electron pair acceptors), polarising bonds or stabilising negative charges that accumulate on transition state intermediates.
• Generating Powerful Nucleophiles: Coordinate bonds can polarise water molecules (e.g., $\text{Zn}^{2+}-\text{OH}_2$), lowering their $\text{p}K_{\text{a}}$ and generating highly reactive hydroxide nucleophiles ($\text{OH}^-$) at neutral pH.

5. Enzyme Kinetics and the Michaelis-Menten Model

Enzyme kinetics is the quantitative study of the rates of enzyme-catalysed reactions and how they are affected by chemical and physical variables.

Chemical Reaction Kinetics and Reaction Orders

Chemical reactions are classified into different kinetic categories based on the relationship between reactant concentrations and the rate of the reaction:

• First-Order Reactions: The rate of the reaction is directly proportional to the concentration of a single reactant. For the reaction $\text{A} \rightarrow \text{P}$:
  $$ \text{Rate} = -\frac{d[\text{A}]}{dt} = k[\text{A}]^1 $$
  where $k$ is the first-order rate constant (with units of $\text{s}^{-1}$). Doubling the concentration of reactant $\text{A}$ doubles the reaction rate.
• Second-Order Reactions: The rate depends on the concentrations of two reactants, or the square of a single reactant concentration. For the reaction $\text{A} + \text{B} \rightarrow \text{P}$:
  $$ \text{Rate} = k[\text{A}]^1[\text{B}]^1 $$
  where $k$ is the second-order rate constant (with units of $\text{M}^{-1}\text{s}^{-1}$).
• Zero-Order Reactions: The rate of the reaction is completely independent of reactant concentration:
  $$ \text{Rate} = k[\text{A}]^0 = k $$
  where $k$ is the zero-order rate constant (with units of $\text{M s}^{-1}$). Altering the concentration of reactant $\text{A}$ has no effect on the rate.

Saturation Kinetics of Enzyme-Catalysed Reactions

When the initial rate of an enzyme-catalysed reaction ($\text{V}_0$) is plotted against the substrate concentration ($[\text{S}]$) at a constant enzyme concentration, a characteristic rectangular hyperbola is obtained, illustrating the phenomenon of substrate saturation:

        Initial Velocity (V0)
          ^
          |                     ----------------------- Vmax
          |                  .-'
          |                .-'
          |             .-'  <-- Zero-Order Region (V0 independent of [S])
          |           .-'
          |  Vmax/2 -+--.  <-- Km
          |        .-'  |
          |      .-'    |
          |    .-'      |  <-- First-Order Region (V0 proportional to [S])
          |  .-'        |
          +-------------+---------------------------------------------> Substrate [S]
                        Km

This saturation curve is divided into two distinct kinetic regions:

• First-Order Region ($[\text{S}] \ll K_{\text{m}}$): At low substrate concentrations, the initial velocity ($\text{V}_0$) increases almost linearly with increasing $[\text{S}]$. The rate of the reaction is directly proportional to substrate concentration.
• Zero-Order Region ($[\text{S}] \gg K_{\text{m}}$): At high substrate concentrations, the active sites of virtually all enzyme molecules are saturated with substrate, existing as the enzyme-substrate ($\text{ES}$) complex. Under these conditions, the velocity reaches a maximum plateau, termed $\text{V}_{\text{max}}$, and is completely independent of further increases in $[\text{S}]$.

The Briggs-Haldane Steady-State Derivation

Leonor Michaelis and Maud Menten proposed a general kinetic model in 1913, which was later refined by G. E. Briggs and J. B. S. Haldane in 1925 using the steady-state assumption. The standard reaction scheme for a single-substrate enzyme-catalysed reaction is written as:

$$ \text{E} + \text{S} \underset{k_{-1}}{\overset{k_1}{\rightleftharpoons}} \text{ES} \xrightarrow{k_2} \text{E} + \text{P} $$

where:

• $k_1$ is the rate constant for the association of enzyme and substrate to form the $\text{ES}$ complex.
• $k_{-1}$ is the rate constant for the dissociation of the $\text{ES}$ complex back into free $\text{E}$ and $\text{S}$.
• $k_2$ (also referred to as $k_{\text{cat}}$) is the rate constant for the conversion of the $\text{ES}$ complex into free enzyme and product.

The Steady-State Assumption

Briggs and Haldane postulated that during the course of the reaction, after a brief initial transient phase, the concentration of the enzyme-substrate complex ($\text{ES}$) remains relatively constant over time:

$$ \frac{d[\text{ES}]}{dt} = 0 $$

This steady-state condition is reached when the rate of formation of the $\text{ES}$ complex is equal to the rate of its breakdown:

$\text{Rate of ES Formation} = \text{Rate of ES Breakdown}$

Using the rate constants from the reaction scheme:

$\text{Rate of ES Formation} = k_1[\text{E}][\text{S}]$
$\text{Rate of ES Breakdown} = (k_{-1} + k_2)[\text{ES}]$

Equating these two rates:

$$ k_1[\text{E}][\text{S}] = (k_{-1} + k_2)[\text{ES}] $$

Rearranging the equation to solve for the ratio of free species to the complex:

$$ \frac{[\text{E}][\text{S}]}{[\text{ES}]} = \frac{k_{-1} + k_2}{k_1} = K_{\text{m}} $$

This ratio of rate constants is defined as the Michaelis constant ($K_{\text{m}}$):

$$ K_{\text{m}} = \frac{k_{-1} + k_2}{k_1} $$

Conservation of Enzyme Mass

The total enzyme concentration ($[\text{E}]_{\text{t}}$) is equal to the sum of the free enzyme ($[\text{E}]$) and the enzyme bound in the complex ($[\text{ES}]$):

$$ [\text{E}]_{\text{t}} = [\text{E}] + [\text{ES}] \implies [\text{E}] = [\text{E}]_{\text{t}} – [\text{ES}] $$

Substituting this expression for $[\text{E}]$ back into the steady-state equation:

$$ \frac{([\text{E}]_{\text{t}} – [\text{ES}])[\text{S}]}{[\text{ES}]} = K_{\text{m}} $$

Expanding the numerator:

$$ \frac{[\text{E}]_{\text{t}}[\text{S}] – [\text{ES}][\text{S}]}{[\text{ES}]} = K_{\text{m}} $$

Splitting the fraction:

$$ \frac{[\text{E}]_{\text{t}}[\text{S}]}{[\text{ES}]} – [\text{S}] = K_{\text{m}} $$

Adding $[\text{S}]$ to both sides:

$$ \frac{[\text{E}]_{\text{t}}[\text{S}]}{[\text{ES}]} = K_{\text{m}} + [\text{S}] $$

Solving for $[\text{ES}]$:

$$ [\text{ES}] = \frac{[\text{E}]_{\text{t}}[\text{S}]}{K_{\text{m}} + [\text{S}]} $$

Relating ES to Velocity

According to the law of mass action, the initial rate of product formation ($\text{V}_0$) is determined by the rate-limiting step of the reaction:

$$ \text{V}_0 = k_2[\text{ES}] $$

Substituting the expression for $[\text{ES}]$ into this rate equation:

$$ \text{V}_0 = \frac{k_2[\text{E}]_{\text{t}}[\text{S}]}{K_{\text{m}} + [\text{S}]} $$

The maximum possible velocity ($\text{V}_{\text{max}}$) occurs when all available enzyme is saturated with substrate ($[\text{ES}] = [\text{E}]_{\text{t}}$):

$$ \text{V}_{\text{max}} = k_2[\text{E}]_{\text{t}} $$

Substituting $\text{V}_{\text{max}}$ into the velocity equation yields the classic Michaelis-Menten Equation:

$$ \text{V}_0 = \frac{\text{V}_{\text{max}}[\text{S}]}{K_{\text{m}} + [\text{S}]} $$

Quantitative Parameters: $K_{\text{m}}$, $k_{\text{cat}}$, and $k_{\text{cat}}/K_{\text{m}}$

The Michaelis-Menten equation contains three fundamental kinetic constants that define the functional properties of an enzyme:

1. The Michaelis Constant ($K_{\text{m}}$)

• Physical Definition: $K_{\text{m}}$ is the specific substrate concentration at which the initial reaction velocity is exactly half-maximal ($\text{V}_0 = \frac{1}{2}\text{V}_{\text{max}}$).
• Derivation: If $[\text{S}] = K_{\text{m}}$:
  $$ \text{V}_0 = \frac{\text{V}_{\text{max}}K_{\text{m}}}{K_{\text{m}} + K_{\text{m}}} = \frac{\text{V}_{\text{max}}K_{\text{m}}}{2K_{\text{m}}} = \frac{1}{2}\text{V}_{\text{max}} $$
• Relationship to Affinity: $K_{\text{m}}$ is unique to each enzyme-substrate pair and is independent of enzyme concentration. When $k_2 \ll k_{-1}$ (the rate of product formation is much slower than the rate of substrate dissociation), $K_{\text{m}}$ simplifies to:
  $$ K_{\text{m}} \approx \frac{k_{-1}}{k_1} = K_{\text{s}} $$
  where $K_{\text{s}}$ is the thermodynamic dissociation constant of the $\text{ES}$ complex. Under these conditions, a lower $K_{\text{m}}$ value indicates a higher affinity of the enzyme for its substrate, whereas a higher $K_{\text{m}}$ indicates a weaker affinity. For most enzymes, $K_{\text{m}}$ lies between $10^{-1}$ and $10^{-7}\ \text{M}$.

2. The Turnover Number ($k_{\text{cat}}$)

• Physical Definition: Also termed the catalytic constant, $k_{\text{cat}}$ is the number of substrate molecules converted into product per active site per unit time when the enzyme is fully saturated with substrate.
• Calculation:
  $$ k_{\text{cat}} = \frac{\text{V}_{\text{max}}}{[\text{E}]_{\text{t}}} $$
  with units of reciprocal time ($\text{s}^{-1}$). It represents the kinetic efficiency of the catalytic step. For example, catalase has an exceptionally high turnover number of $4 \times 10^7\ \text{s}^{-1}$, whereas lysozyme is relatively slow, with a $k_{\text{cat}}$ of approximately $0.5\ \text{s}^{-1}$.

3. The Specificity Constant ($k_{\text{cat}}/K_{\text{m}}$)

• Physical Definition: A measure of how efficiently an enzyme converts substrate into product at low substrate concentrations ($[\text{S}] \ll K_{\text{m}}$). Under these non-saturating conditions, the concentration of free enzyme ($[\text{E}]$) is approximately equal to total enzyme ($[\text{E}]_{\text{t}}$), and the rate equation simplifies to:
  $$ \text{V}_0 \approx \left(\frac{k_{\text{cat}}}{K_{\text{m}}}\right)[\text{E}][\text{S}] $$
• Kinetic Significance: The ratio $k_{\text{cat}}/K_{\text{m}}$ (with units of $\text{M}^{-1}\text{s}^{-1}$) is the second-order rate constant for the reaction of free enzyme with substrate. It provides an index of catalytic efficiency and substrate preference.
• Limit of Catalytic Perfection: The value of $k_{\text{cat}}/K_{\text{m}}$ is physically limited by the rate at which enzyme and substrate molecules collide in aqueous solution. This diffusion-controlled limit is approximately $10^8$ to $10^9\ \text{M}^{-1}\text{s}^{-1}$. Enzymes operating near this limit are said to have achieved “catalytic perfection.”

6. Linear Graphical Representations of Kinetics

Determining the values of $K_{\text{m}}$ and $\text{V}_{\text{max}}$ directly from a hyperbolic plot of $\text{V}_0$ versus $[\text{S}]$ is mathematically difficult, as $\text{V}_{\text{max}}$ is approached asymptotically. To address this, several linear transformations of the Michaelis-Menten equation are used to plot kinetic data.

The Lineweaver-Burk (Double-Reciprocal) Plot

Derived by taking the reciprocal of both sides of the Michaelis-Menten equation:

$$ \frac{1}{\text{V}_0} = \frac{K_{\text{m}} + [\text{S}]}{\text{V}_{\text{max}}[\text{S}]} = \frac{K_{\text{m}}}{\text{V}_{\text{max}}[\text{S}]} + \frac{[\text{S}]}{\text{V}_{\text{max}}[\text{S}]} $$
$$ \frac{1}{\text{V}_0} = \left(\frac{K_{\text{m}}}{\text{V}_{\text{max}}}\right)\frac{1}{[\text{S}]} + \frac{1}{\text{V}_{\text{max}}} $$

This is a linear equation in the form $y = mx + c$, where:

• $y$-axis variable: $\frac{1}{\text{V}_0}$
• $x$-axis variable: $\frac{1}{[\text{S}]}$
• Slope ($m$): $\frac{K_{\text{m}}}{\text{V}_{\text{max}}}$
• $y$-intercept ($c$): $\frac{1}{\text{V}_{\text{max}}}$
• $x$-intercept (when $y=0$): $-\frac{1}{K_{\text{m}}}$

     1/V0
       ^
       |             / (Slope = Km/Vmax)
       |            /
       |           /
       |          /
       |         /
       |        /
       |       / 1/Vmax (y-intercept)
 ------+------/-----------------------------> 1/[S]
      /|     /
     / |    /
-1/Km  |   /
(x-intercept)

Note on Limitation: This plot compresses high-substrate data points near the origin and spreads out low-substrate data points, making it highly sensitive to experimental errors at low substrate concentrations.

The Hanes-Woolf Plot

Derived by multiplying the Lineweaver-Burk equation by $[\text{S}]$:

$$ \frac{[\text{S}]}{\text{V}_0} = \left(\frac{1}{\text{V}_{\text{max}}}\right)[\text{S}] + \frac{K_{\text{m}}}{\text{V}_{\text{max}}} $$

This yields a straight line where:

• $y$-axis variable: $\frac{[\text{S}]}{\text{V}_0}$
• $x$-axis variable: $[\text{S}]$
• Slope: $\frac{1}{\text{V}_{\text{max}}}$
• $y$-intercept: $\frac{K_{\text{m}}}{\text{V}_{\text{max}}}$
• $x$-intercept: $-K_{\text{m}}$

 [S]/V0
   ^
   |           / (Slope = 1/Vmax)
   |          /
   |         /
   |        / Km/Vmax (y-intercept)
 --+-------/--------------------------> [S]
  /|      /
 / |     /
-Km|    /
(x-intercept)

The Eadie-Hofstee Plot

Derived by multiplying both sides of the Michaelis-Menten equation by $(K_{\text{m}} + [\text{S}])$ and rearranging terms:

$$ \text{V}_0(K_{\text{m}} + [\text{S}]) = \text{V}_{\text{max}}[\text{S}] \implies \text{V}_0 K_{\text{m}} + \text{V}_0[\text{S}] = \text{V}_{\text{max}}[\text{S}] $$

Dividing by $[\text{S}]$:

$$ \text{V}_0\frac{K_{\text{m}}}{[\text{S}]} + \text{V}_0 = \text{V}_{\text{max}} $$

Solving for $\text{V}_0$:

$$ \text{V}_0 = -K_{\text{m}}\left(\frac{\text{V}_0}{[\text{S}]}\right) + \text{V}_{\text{max}} $$

This yields a straight line where:

• $y$-axis variable: $\text{V}_0$
• $x$-axis variable: $\frac{\text{V}_0}{[\text{S}]}$
• Slope: $-K_{\text{m}}$
• $y$-intercept: $\text{V}_{\text{max}}$
• $x$-intercept: $\frac{\text{V}_{\text{max}}}{K_{\text{m}}}$

  V0
   ^
   | \ (Slope = -Km)
   |  \
   |   \
   |    \
   |     \
 --+------+-----------------------------> V0/[S]
   |      Vmax/Km (x-intercept)

7. Environmental Effects on Catalysis

The catalytic activity of an enzyme is highly dependent on environmental parameters, particularly temperature and pH.

Temperature Effects

Plotted as reaction velocity versus temperature, enzymes exhibit a characteristic asymmetric, bell-shaped curve:

        Percent Maximum Activity
          ^
          |               /\
          |              /  \
          |             /    \  <-- Thermal Denaturation Phase
          |            /      \
          |    _ _ _ _/        \
          |   /                 \
          +--+----+----+----+----+----+---> Temperature (°C)
             0    20   40   60   80   100

This temperature profile reflects the balance between two competing physical processes:

1. Kinetic Acceleration: Below the optimum temperature, an increase in temperature increases the thermal kinetic energy of the molecules. This increases the rate of molecular collisions and the frequency of transition-state crossings. As a general rule of thumb, the rate of a typical chemical reaction approximately doubles for every 10°C rise in temperature.
2. Thermal Denaturation: Above a critical temperature, the kinetic energy of the system becomes high enough to disrupt the weak, non-covalent interactions (hydrogen bonds, hydrophobic interactions) that stabilise the tertiary structure of the enzyme. This leads to unfolding, loss of active site architecture, and complete loss of catalytic activity.

The optimum temperature represents the point of maximum catalytic activity before thermal denaturation becomes dominant. While most human enzymes have an optimum temperature around 37°C, enzymes from thermophilic organisms, such as Taq DNA Polymerase from Thermus aquaticus, operate optimally at high temperatures (e.g., 72°C) and resist denaturation at temperatures up to 95°C.

pH Effects

Most enzymes function within a narrow physiological pH range, typically between 5 and 9. When plotted, enzyme activity versus pH generally displays a symmetrical, bell-shaped curve.

        Pepsin (Optimum ~1.5)      Catalase (Optimum ~7.6)     Arginase (Optimum ~9.7)
              /\                        /\                           /\
             /  \                      /  \                         /  \
            /    \                    /    \                       /    \
          -+------+--               -+------+--                  -+------+--
           0  2   4                  5  7   9                     8  10  12   pH

Changes in pH alter the catalytic rate through several mechanisms:

• Active Site Ionization: Catalysis often requires specific amino acid residues in the active site to exist in a particular ionic state (e.g., a general acid must be protonated, while a general base must be deprotonated).
• Substrate Ionization: Variations in pH can change the charge of the substrate molecule, disrupting binding interactions.
• Structural Denaturation: Extreme pH values disrupt ionic and hydrogen bonds that maintain the native conformation of the protein, leading to denaturation.

Kinetics of Bi-substrate (Multireactant) Systems

While the Michaelis-Menten model assumes a single substrate, the majority of biochemical reactions involve two or more distinct substrates:

$$ \text{A} + \text{B} \rightleftharpoons \text{P} + \text{Q} $$

Bi-substrate reactions generally proceed through one of two distinct kinetic mechanisms:

1. Sequential (Single-Displacement) Reactions

Both substrates ($\text{A}$ and $\text{B}$) must bind to the enzyme active site to form a ternary complex ($\text{EAB}$) before any product can be released. Sequential reactions are divided into two classes:

• Ordered Sequential: Substrates must bind in a specific, mandatory sequence. Substrate $\text{A}$ must bind first, inducing a conformational change that creates the binding site for substrate $\text{B}$. Similarly, products must be released in a specific order:

     A          B                 P          Q
     |          |                 |          |
     v          v                 v          v
  +--+----------+-------+      +--+----------+-------+
  |  E ->  EA  ->  EAB  | ===> | E ->  EPQ  ->  EQ ->| E
  +---------------------+      +---------------------+
  

• Random Sequential: Substrates can bind in any order ($\text{A}$ then $\text{B}$, or $\text{B}$ then $\text{A}$). There is no mandatory binding sequence.

2. Double-Displacement (Ping-Pong) Reactions

One substrate binds to the enzyme first and is converted into product, chemically transferring a group to the enzyme to form a modified enzyme intermediate ($\text{E’}$). The first product ($\text{P}$) dissociates before the second substrate ($\text{B}$) binds. Substrate $\text{B}$ then accepts the transferred group from the modified enzyme, converting $\text{E’}$ back into its original state ($\text{E}$) and releasing the second product ($\text{Q}$):

   A          P            B          Q
   |          v            |          v
   v          |            v          |
+--+----------+--+      +--+----------+--+
|  E -> EA -> E' | ===> | E' -> E'B -> E |
+----------------+      +----------------+

8. Reversible and Irreversible Inhibition

Enzyme inhibitors are chemical agents that bind to enzymes, reducing their catalytic activity. They are divided into two major functional classes based on the nature of their binding:

Irreversible Inhibition

Irreversible inhibitors bind to the enzyme, typically via covalent bonds, chemically altering or destroying a functional group in the active site that is essential for catalytic activity.

• Suicide (Mechanism-Based) Inhibitors: These are relatively unreactive molecules that structurally resemble the substrate. They bind to the active site and undergo the first few steps of the normal catalytic pathway. However, instead of being converted into product, they are transformed into a highly reactive intermediate that forms an irreversible covalent bond with a functional group in the active site, inactivating the enzyme.
  
  Examples include:
  • Penicillin: Actively inactivates glycopeptide transpeptidase, preventing bacterial cell wall cross-linking and leading to osmotic lysis.
  • Aspirin: Covalently acetylates a critical serine residue in the active site of cyclooxygenase, blocking prostaglandin synthesis.
• Classic Irreversible Inhibitors:
  • Diisopropyl fluorophosphate (DIPF): Organophosphate compound that selectively reacts with and binds covalently to active-site serine residues (e.g., in chymotrypsin and acetylcholinesterase), forming a stable diisopropylphosphoryl-enzyme derivative.
  • Sarin: Volatile organophosphate nerve agent that covalently binds to the active-site serine of acetylcholinesterase, halting neurotransmitter degradation and causing continuous muscular stimulation.
  • Physostigmine & Parathion: Carbamate and organophosphate compounds that act as potent acetylcholinesterase inhibitors.

Reversible Inhibition

Reversible inhibitors associate with and dissociate from the enzyme via weak, non-covalent interactions. They are divided into three major categories based on their binding site preferences:

A. Competitive:                    B. Uncompetitive:                  C. Non-Competitive:
      +-------+                          +-------+                          +-------+
      |  E/ES | <---+                    |   ES  | <---+                    | E/ES  | <---+
      +-------+     |                    +-------+     |                    +-------+     |
         ^          |                       ^          |                       ^          |
         | [S]      | [I]                   | [S]      | [I]                   | [S]      | [I]
         v          |                       v          |                       v          |
      +-------+     |                    +-------+     |                    +-------+     |
      | Active|-----+                    | Complex     |-----+              | Allos-  |-----+
      |  Site |                          |  Neck   |                        |  teric  |
      +-------+                          +---------+                        +---------+

1. Competitive Inhibition

• Mechanism: The inhibitor ($\text{I}$) structurally resembles the substrate ($\text{S}$) and competes directly with it for binding to the free enzyme active site. It can form an enzyme-inhibitor complex ($\text{EI}$), but this prevents the substrate from binding:
  $$ \text{E} + \text{I} \rightleftharpoons \text{EI} $$
• Kinetic Impact: High substrate concentrations ($[\text{S}] \gg [\text{I}]$) can outcompete and displace the inhibitor from the active site, restoring the full catalytic rate. Therefore:
  • $\text{V}_{\text{max}}$ remains unchanged.
  • The apparent $K_{\text{m}}$ increases by an alpha factor ($\alpha K_{\text{m}}$):
    $$ \alpha = 1 + \frac{[\text{I}]}{K_{\text{i}}} \quad \text{where} \quad K_{\text{i}} = \frac{[\text{E}][\text{I}]}{[\text{EI}]} $$
• Double-Reciprocal Plot: The lines with and without inhibitor intersect on the $y$-axis ($1/\text{V}_{\text{max}}$).

2. Uncompetitive Inhibition

• Mechanism: The inhibitor binds exclusively to the enzyme-substrate ($\text{ES}$) complex at a distinct site that is created only after substrate binding. It does not compete with the substrate for the free enzyme:
  $$ \text{ES} + \text{I} \rightleftharpoons \text{ESI} $$
• Kinetic Impact: Because the inhibitor removes active $\text{ES}$ complexes, the overall catalytic rate decreases. High substrate concentrations cannot outcompete or reverse this inhibition. Therefore:
  • $\text{V}_{\text{max}}$ decreases ($\text{V}_{\text{max,app}} = \text{V}_{\text{max}}/\alpha’$).
  • The apparent $K_{\text{m}}$ decreases by the same factor ($K_{\text{m,app}} = K_{\text{m}}/\alpha’$):
    $$ \alpha’ = 1 + \frac{[\text{I}]}{K_{\text{i}}’} \quad \text{where} \quad K_{\text{i}}’ = \frac{[\text{ES}][\text{I}]}{[\text{ESI}]} $$
• Double-Reciprocal Plot: The lines are parallel, having the same slope ($K_{\text{m}}/\text{V}_{\text{max}}$).

3. Non-Competitive Inhibition

• Mechanism: The inhibitor binds to a site other than the active site (an allosteric site) on both the free enzyme ($\text{E}$) and the enzyme-substrate complex ($\text{ES}$):
  $$ \text{E} + \text{I} \rightleftharpoons \text{EI} \quad \text{and} \quad \text{ES} + \text{I} \rightleftharpoons \text{ESI} $$
• Pure Non-Competitive Inhibition: The inhibitor has equal affinity for both free $\text{E}$ and the $\text{ES}$ complex ($K_{\text{i}} = K_{\text{i}}’$). Under these conditions:
  • $\text{V}_{\text{max}}$ decreases ($\text{V}_{\text{max,app}} = \text{V}_{\text{max}}/\alpha$).
  • $K_{\text{m}}$ remains unchanged, as the binding of the inhibitor does not affect the affinity of the enzyme for its substrate.
• Mixed Non-Competitive Inhibition: The inhibitor binds to $\text{E}$ and $\text{ES}$ with different affinities ($K_{\text{i}} \neq K_{\text{i}}’$). Under these conditions:
  • $\text{V}_{\text{max}}$ decreases.
  • The apparent $K_{\text{m}}$ can increase or decrease, depending on whether the inhibitor prefers the free enzyme or the $\text{ES}$ complex.
• Double-Reciprocal Plot: The lines intersect to the left of the $y$-axis. For pure non-competitive inhibition, the intersection point lies on the $x$-axis ($-1/K_{\text{m}}$).

Lineweaver-Burk Profiles of Reversible Inhibition

The characteristic double-reciprocal plots for each major class of reversible inhibition are illustrated below:

A. Competitive Inhibition            B. Uncompetitive Inhibition          C. Pure Non-Competitive
       1/V0                                 1/V0                                 1/V0
         ^  / (With Inhibitor)                ^    / (With Inhibitor)              ^    / (With Inhibitor)
         | /                                  |   /                                |   /
         |/                                   |  /   /                             |  /
         |  _ _ (No Inhibitor)                | /   / (No Inhibitor)               | /  _ _ (No Inhibitor)
         |/                                   |/   /                               |/
 --------+------------------> 1/[S]       ----+--------------------> 1/[S]     ----+--------------------> 1/[S]
        /|                                   /|                                   /|
  -1/αKm | (Intersect on y-axis)            / |                                   | (Intersect on x-axis)
         |                                    |                            -1/Km   |

Representative Physiological Examples of Reversible Inhibition

• Methotrexate (Amethopterin): A structural analogue of dihydrofolate that acts as a potent competitive inhibitor of dihydrofolate reductase (DHFR). It prevents the synthesis of tetrahydrofolate, blocking nucleotide synthesis and cell division in rapidly proliferating cancer cells.
• Allopurinol: A structural analogue of hypoxanthine that competitively inhibits xanthine oxidase. It blocks the conversion of purines into uric acid, reducing joint inflammation in patients with gout.
• Sulfonamides (Sulfa Drugs): Structural analogues of para-aminobenzoic acid ($\text{PABA}$) that competitively inhibit bacterial dihydropteroate synthase, blocking folate synthesis in bacteria without affecting mammalian cells.
• Malonate: A structural analogue of succinate that competitively inhibits succinate dehydrogenase in the citric acid cycle.
• Methanol Poisoning Treatment: Methanol is metabolised by alcohol dehydrogenase into highly toxic formaldehyde. Ethanol is administered as a competitive inhibitor of alcohol dehydrogenase; it competes with methanol for the active site of the enzyme and decreases the formation of formaldehyde, allowing it to be safely excreted.

9. Regulatory Control of Enzymes

To coordinate metabolic pathways and respond to environmental changes, cells employ several mechanisms to regulate enzyme activity:

Allosteric Regulation

Allosteric enzymes are oligomeric proteins (composed of multiple interacting subunits) that do not obey classic Michaelis-Menten kinetics.

• Allosteric Sites: In addition to their active sites, these enzymes possess distinct regulatory (allosteric) sites where non-covalent modulators bind.
• Conformational Transitions (T and R States): Allosteric enzymes transition between two primary conformational states:
  • $\text{T}$ (Tense/Taut) State: Low affinity for substrate, catalytically less active.
  • $\text{R}$ (Relaxed) State: High affinity for substrate, catalytically highly active.
• Modulators:
  • Positive Modulators (Activators): Stabilise the active $\text{R}$ state, shifting the substrate-saturation curve to the left (decreasing the apparent $K_{\text{m}}$ or $K_{0.5}$).
  • Negative Modulators (Inhibitors): Stabilise the inactive $\text{T}$ state, shifting the curve to the right (increasing the apparent $K_{0.5}$).
• Cooperativity: Substrate binding to one subunit induces a conformational transition that increases the binding affinity of adjacent subunits. This cooperative behavior generates a characteristic sigmoidal (S-shaped) substrate-saturation curve rather than a rectangular hyperbola:

        Initial Velocity (V0)
          ^
          |            /---\  <-- Positive Modulator (Activator) (Shifts left)
          |          /       \
          |        / _ _ _ _  \ <-- Control (Sigmoidal Cooperativity)
          |       / /          \
          |      / /            \ <-- Negative Modulator (Inhibitor) (Shifts right)
          |     / /              \
          +----+----+----+----+----+---> Substrate [S]

Theoretical Models for Allosteric Transitions

• The Concerted (MWC) Model (Monod, Wyman, Changeux, 1965): Proposes that all subunits of an oligomeric enzyme must exist in the same conformational state simultaneously ($\text{T}_n$ or $\text{R}_n$). Perfect molecular symmetry is preserved throughout the transition; hybrid states ($\text{T/R}$ mixtures) are forbidden.
• The Sequential (KNF) Model (Koshland, Némethy, Filmer, 1966): Proposes that substrate binding to one subunit induces a conformational change in only that subunit. This change then alters the binding affinity of adjacent subunits through conformational stress, allowing for sequential transitions and hybrid states. This model can account for both positive and negative cooperativity.

Reversible Covalent Modification

Enzyme activity can be regulated through the covalent addition or removal of specific chemical groups, driven by separate regulatory enzymes:

• Glycogen Phosphorylase: Phosphorylation (Phosphorylase kinase adds phosphate; active form is a)
• Glycogen Synthase: Phosphorylation (Phosphorylating inactivates; active form is dephosphorylated)
• Acetyl-CoA carboxylase: Phosphorylation
• Glutamine synthetase (E. coli): Adenylylation
• Nitrogenase: ADP-ribosylation

The Phosphorylation Paradigm: Glycogen Metabolism

The coordinate regulation of glycogen synthesis and breakdown is mediated by reversible phosphorylation:

• Glycogen Phosphorylase: Catalyses glycogen breakdown. It is active in its phosphorylated form (Phosphorylase a) and less active in its dephosphorylated form (Phosphorylase b).
• Glycogen Synthase: Catalyses glycogen synthesis. It is active in its dephosphorylated form and inactivated upon phosphorylation by protein kinases.

Zymogen Activation

A zymogen (or proenzyme) is an inactive polypeptide precursor that must undergo selective, irreversible proteolytic cleavage to expose its active site and become functionally active.

Trypsinogen and Chymotrypsinogen Activation Cascades

In the duodenum, pancreatic zymogens are sequentially activated to prevent premature autodigestion of pancreatic tissue:

• The intestinal brush-border enzyme enteropeptidase cleaves a specific hexapeptide from the N-terminus of trypsinogen, converting it into active trypsin.
• Active trypsin then acts autocatalytically to activate remaining trypsinogen molecules. It also cleaves the peptide bond between $\text{Arg}^{15}$ and $\text{Ile}^{16}$ in chymotrypsinogen, converting it into the transient, catalytically active $\pi$-chymotrypsin.
• Two subsequent autolytic cleavages remove two dipeptides ($\text{Ser}^{14}-\text{Arg}^{15}$ and $\text{Thr}^{147}-\text{Asn}^{148}$), rearranging the structure into the mature, highly active $\alpha$-chymotrypsin consisting of three polypeptide chains held together by disulfide bonds:

        Chymotrypsinogen (Inactive, 245 residues)
               |
               |  <--- Trypsin cleavage (Arg15 - Ile16)
               v
        π-Chymotrypsin (Active)
               |
               |  <--- Autolytic cleavages (Releases Ser14-Arg15 and Thr147-Asn148)
               v
        α-Chymotrypsin (Fully active, three chains connected by disulfide bonds)

Feedback Inhibition versus Feedback Repression

Metabolic pathways are regulated through negative feedback loops that respond to the accumulation of end products:

• Feedback Inhibition: The end product of a metabolic pathway binds directly to and inhibits the first committed enzyme of the pathway, rapidly adjusting the rate of product synthesis (e.g., isoleucine inhibiting threonine deaminase). This is a post-translational regulatory mechanism operating at the enzyme activity level.
• Feedback Repression: The end product acts at the genetic level, binding to a repressor protein to block the transcription of the genes encoding the pathway enzymes. This adjusts the total amount of enzyme synthesised and is a slower, transcription-level regulatory mechanism (e.g., tryptophan acting as a co-repressor to shut down the transcription of the tryptophan operon).

10. Alternative Catalytic Paradigms

Beyond standard proteinaceous enzymes, biological systems utilize several alternative catalytic structures:

Isozymes (Isoenzymes)

Isozymes are distinct proteins that catalyse the same chemical reaction but differ in their amino acid sequence, kinetic parameters ($K_{\text{m}}$, $\text{V}_{\text{max}}$), regulatory properties, or tissue distribution.

Lactate Dehydrogenase (LDH)

LDH is a tetrameric enzyme composed of two distinct subunit types: the $\text{H}$ (Heart) subunit and the $\text{M}$ (Muscle) subunit. These assemble into five distinct isozyme configurations with tissue-specific roles:

• $\text{LDH}_1$ ($\text{H}_4$): Highly abundant in heart tissue and red blood cells; operates optimally under aerobic conditions to convert lactate into pyruvate.
• $\text{LDH}_2$ ($\text{H}_3\text{M}_1$): Abundant in the reticuloendothelial system.
• $\text{LDH}_3$ ($\text{H}_2\text{M}_2$): Predominant in lung tissue.
• $\text{LDH}_4$ ($\text{H}_1\text{M}_3$): Found in kidney and placental tissues.
• $\text{LDH}_5$ ($\text{M}_4$): Highly abundant in skeletal muscle and liver tissue; operates under anaerobic conditions to convert pyruvate into lactate.

Hexokinase versus Glucokinase

• Hexokinases I, II, and III: Present in most non-hepatic tissues. They possess a very low $K_{\text{m}}$ for glucose ($< 1\ \text{mM}$), allowing them to operate at near-maximal rates even at low fasting blood glucose levels. They are strongly inhibited by their product, glucose 6-phosphate.
• Hexokinase IV (Glucokinase): Expressed primarily in liver cells and pancreatic beta cells. It has a high $K_{\text{m}}$ for glucose (approximately $10\ \text{mM}$), meaning its activity increases in direct proportion to blood glucose levels after a meal. It is not inhibited by glucose 6-phosphate, allowing the liver to continually clear glucose from the bloodstream.

Ribozymes (RNA Catalysts)

Discovered independently by Thomas Cech and Sidney Altman in the 1980s, ribozymes are catalytic RNA molecules that can cleave phosphodiester bonds or catalyse peptide bond formation.

• Peptidyl Transferase Activity: The active site of the large ribosomal subunit is composed entirely of RNA. In prokaryotes, the 23S rRNA (and in eukaryotes, the 28S rRNA) acts as a ribozyme to catalyse peptide bond formation during translation.
• Other Examples: RNase P (which processes precursor tRNAs), group I and group II self-splicing introns, and the hammerhead ribozyme.

DNAzymes and Abzymes

• DNAzymes (Deoxyribozymes): Synthetic single-stranded DNA molecules with catalytic activity, generated in the laboratory through in vitro selection.
• Abzymes (Catalytic Antibodies): Monoclonal antibodies raised against stable chemical analogues of transition states. Because the antibody binding site is complementary to the transition state, it stabilises this conformation, lowering the activation energy and catalysing the reaction.

11. Comprehensive Mechanistic Case Studies

The physical-chemical principles of catalysis are illustrated by four classic enzyme mechanisms:

Lysozyme (EC 3.2.1.17)

Lysozyme is a hydrolytic enzyme that protects against bacterial infection by cleaving the $\beta(1\rightarrow4)$ glycosidic bonds linking $N$-acetylmuramic acid ($\text{NAM}$) and $N$-acetylglucosamine ($\text{NAG}$) in the peptidoglycan cell wall of Gram-positive bacteria.

       Active Site binding sub-sites (A to F):
       [ NAG ] [ NAM ] [ NAG ] [ NAM ] * [ NAG ] [ NAM ]
          A       B       C       D    |    E       F
                                       |
                                 Cleavage Site
                               (Between D and E)

Active Site Geometry

The active site accommodates six sugar residues (labelled $\text{A}$ through $\text{F}$). The cleavage occurs between residues $\text{D}$ and $\text{E}$. Residue $\text{D}$ (a $\text{NAM}$ sugar) is sterically forced into a strained, half-chair conformation to fit within the binding pocket. This distortion destabilises the ground state, facilitating cleavage.

Catalytic Mechanism

Two key amino acid residues participate directly in the cleavage reaction between sub-sites $\text{D}$ and $\text{E}$:

• Glutamate-35 ($\text{Glu}^{35}$): Located in a hydrophobic microenvironment, which prevents its ionization and raises its $\text{p}K_{\text{a}}$ value to approximately 6.2. It acts as a general acid, donating a proton to the glycosidic oxygen atom linking residues $\text{D}$ and $\text{E}$, which cleaves the bond and releases the $\text{E-F}$ disaccharide product.
• Aspartate-52 ($\text{Asp}^{52}$): Located in a highly polar, hydrophilic environment that stabilises its negative charge, keeping it ionized ($\text{p}K_{\text{a}} \approx 4.5$). It acts as a nucleophile, attacking the $\text{C1}$ carbon of the strained sugar $\text{D}$ to form a transient, covalent glycosyl-enzyme intermediate (or stabilising the developing oxocarbenium ion intermediate through electrostatic interactions).
• A water molecule from the solvent is deprotonated by $\text{Glu}^{35}$ (now acting as a general base). The resulting hydroxide ion ($\text{OH}^-$) attacks the $\text{C1}$ carbon of residue $\text{D}$, hydrolysing the covalent intermediate, releasing the product, and returning the enzyme to its original catalytic state.

Chymotrypsin

Chymotrypsin is a pancreatic serine protease that cleaves peptide bonds on the carboxyl side of bulky hydrophobic or aromatic amino acids (phenylalanine, tyrosine, tryptophan).

                      THE CATALYTIC TRIAD
         +-----------+    +-----------+    +-----------+
         |  Asp 102  |    |  His 57   |    |  Ser 195  |
         |  (Acid)   |    |  (Base)   |    | (Nucleo-  |
         +-----+-----+    +-----+-----+    |  phile)   |
               |                |          +-----+-----+
               |   O            |   H            |
               | //             |  /             |
               |C--O- - - - - -HN--N- - - - - -H-O
               +-----------+    +-----------+    +-----------+

The Catalytic Triad

The active site contains three amino acid residues that form a hydrogen-bonded charge-relay network: $\text{Ser}^{195}$, $\text{His}^{57}$, and $\text{Asp}^{102}$:

• $\text{Asp}^{102}$ forms a hydrogen bond with $\text{His}^{57}$, polarising the imidazole ring of the histidine residue.
• The polarised $\text{His}^{57}$ acts as a powerful general base, pulling the proton away from the hydroxyl group of $\text{Ser}^{195}$.
• This proton transfer increases the nucleophilicity of the $\text{Ser}^{195}$ oxygen, transforming it into a highly reactive alkoxide-like nucleophile.

Step-by-Step Catalytic Sequence

1. Substrate Binding: The substrate polypeptide binds to the active site. The bulky aromatic side chain fits into a deep, hydrophobic pocket, positioning the target peptide bond adjacent to $\text{Ser}^{195}$.
2. Nucleophilic Attack: The activated oxygen of $\text{Ser}^{195}$ attacks the carbonyl carbon of the substrate peptide bond, forming a transient tetrahedral intermediate. The developing negative charge on the carbonyl oxygen is stabilised by hydrogen bonds within a pocket called the oxyanion hole.
3. Peptide Bond Cleavage: The tetrahedral intermediate collapses. $\text{His}^{57}$ acts as a general acid, donating a proton to the leaving amino group of the cleaved peptide. The C-terminal fragment of the substrate dissociates, leaving the N-terminal fragment covalently linked to the enzyme as an acyl-enzyme intermediate.
4. Water Activation: A water molecule enters the active site. $\text{His}^{57}$ acts as a general base, deprotonating the water molecule to generate a hydroxide nucleophile.
5. Deacylation: The hydroxide ion attacks the carbonyl carbon of the acyl-enzyme intermediate, forming a second tetrahedral intermediate.
6. Intermediate Collapse: This intermediate collapses, cleaving the covalent bond to $\text{Ser}^{195}$. $\text{His}^{57}$ acts as a general acid, donating a proton back to $\text{Ser}^{195}$. The N-terminal peptide fragment dissociates, restoring the enzyme to its original state.

Ribonuclease A (RNase A)

RNase A is an endoribonuclease secreted by the pancreas that catalyses the hydrolytic cleavage of phosphodiester bonds in single-stranded RNA molecules on the $3’$-side of pyrimidine residues (uracil, cytosine).

        1. Transesterification:
           [5'-Nucleoside-O] - P - O - [3'-Nucleoside]
                               |
                               O - [2'-OH of Ribose]  <--- His12 (Base) deprotonates 2'-OH
                               |                           to initiate nucleophilic attack
                               O- (Oxyanion)               on phosphorus atom.
                               |
                               [His119] (Acid) Protons the leaving 5'-alkoxide group.
        2. Cyclic Intermediate:
           Forms a cyclic 2',3'-nucleoside monophosphate intermediate, which is
           subsequently hydrolysed by water (activated by His119 acting as a base).

Catalytic Mechanism

The reaction occurs in two stages, mediated by two critical histidine residues, $\text{His}^{12}$ and $\text{His}^{119}$, which act cooperatively as general acids and bases:

• Transesterification (First Stage):
  • $\text{His}^{12}$ acts as a general base, abstracting a proton from the $2’\text{-OH}$ group of the ribose ring.
  • This activates the $2’$-oxygen to act as a nucleophile, which attacks the adjacent phosphorus atom of the phosphodiester backbone.
  • $\text{His}^{119}$ acts as a general acid, donating a proton to the oxygen of the leaving $5’$-alkoxide group of the adjacent nucleotide, cleaving the phosphodiester bond.
  • This stage results in the formation of a cyclic $2′,3’$-nucleoside monophosphate intermediate and the release of the $5’$-hydroxyl RNA fragment.
• Hydrolysis (Second Stage):
  • The cyclic intermediate is resolved by a water molecule from the solvent.
  • $\text{His}^{119}$ (now unprotonated) acts as a general base, abstracting a proton from water. The resulting hydroxide ion attacks the phosphorus atom of the cyclic intermediate.
  • $\text{His}^{12}$ (now protonated) acts as a general acid, donating a proton to the $2’$-oxygen atom, which cleaves the cyclic bond and yields a terminal $3’$-monophosphate nucleotide product.

Aspartate Proteases

Aspartate proteases (such as pepsin, renin, and HIV protease) utilize two conserved aspartic acid residues in their active sites to cleave peptide bonds. Unlike serine proteases, they do not form a covalent acyl-enzyme intermediate.

Catalytic Mechanism

1. One active-site aspartate residue acts as a general base, abstracting a proton from a water molecule in the active site.
2. The activated water molecule acts as a nucleophile, directly attacking the carbonyl carbon of the substrate peptide bond to form a tetrahedral intermediate.
3. The second active-site aspartate residue acts as a general acid, donating a proton to the nitrogen of the peptide bond, facilitating its cleavage and product release.

12. Quantitative Kinetics Problems (Fully Worked)

Problem 1: Substrate Concentrations and Fractional Velocities

An enzyme-catalysed reaction obeys classic Michaelis-Menten kinetics. Calculate the initial velocity ($\text{V}_0$) as a fraction of $\text{V}_{\text{max}}$ under the following conditions:

1. $[\text{S}] = 0.5 K_{\text{m}}$
2. $[\text{S}] = 4 K_{\text{m}}$

Solution:

The Michaelis-Menten equation is:

$$ \text{V}_0 = \frac{\text{V}_{\text{max}}[\text{S}]}{K_{\text{m}} + [\text{S}]} $$

For $[\text{S}] = 0.5 K_{\text{m}}$: Substitute $[\text{S}] = 0.5 K_{\text{m}}$ into the equation:

$$ \text{V}_0 = \frac{\text{V}_{\text{max}}(0.5 K_{\text{m}})}{K_{\text{m}} + 0.5 K_{\text{m}}} = \frac{0.5 \text{V}_{\text{max}} K_{\text{m}}}{1.5 K_{\text{m}}} $$
$$ \text{V}_0 = \frac{0.5}{1.5}\text{V}_{\text{max}} = \frac{1}{3}\text{V}_{\text{max}} \approx 0.33 \text{V}_{\text{max}} $$

The velocity is exactly one-third ($33.3\%$) of $\text{V}_{\text{max}}$.

For $[\text{S}] = 4 K_{\text{m}}$: Substitute $[\text{S}] = 4 K_{\text{m}}$ into the equation:

$$ \text{V}_0 = \frac{\text{V}_{\text{max}}(4 K_{\text{m}})}{K_{\text{m}} + 4 K_{\text{m}}} = \frac{4 \text{V}_{\text{max}} K_{\text{m}}}{5 K_{\text{m}}} $$
$$ \text{V}_0 = \frac{4}{5}\text{V}_{\text{max}} = 0.80 \text{V}_{\text{max}} $$

The velocity is exactly $80\%$ of $\text{V}_{\text{max}}$.

Problem 2: Determining substrate concentration for a target velocity

At what substrate concentration ($[\text{S}]$) will an enzyme achieve exactly $25\%$ of its maximum catalytic velocity ($\text{V}_{\text{max}}$)? Express your answer in terms of $K_{\text{m}}$.

Solution:

Set $\text{V}_0 = 0.25 \text{V}_{\text{max}}$:

$$ 0.25 \text{V}_{\text{max}} = \frac{\text{V}_{\text{max}}[\text{S}]}{K_{\text{m}} + [\text{S}]} $$

Divide both sides by $\text{V}_{\text{max}}$:

$$ 0.25 = \frac{[\text{S}]}{K_{\text{m}} + [\text{S}]} $$

Multiply both sides by $(K_{\text{m}} + [\text{S}])$:

$$ 0.25(K_{\text{m}} + [\text{S}]) = [\text{S}] $$
$$ 0.25 K_{\text{m}} + 0.25[\text{S}] = [\text{S}] $$

Subtract $0.25[\text{S}]$ from both sides:

$$ 0.25 K_{\text{m}} = 0.75[\text{S}] $$

Solve for $[\text{S}]$:

$$ [\text{S}] = \frac{0.25}{0.75}K_{\text{m}} = \frac{1}{3}K_{\text{m}} \approx 0.33 K_{\text{m}} $$

The enzyme achieves $25\%$ of $\text{V}_{\text{max}}$ when the substrate concentration is exactly one-third of its $K_{\text{m}}$ value.

Problem 3: Quantitative Inhibition Analysis

An enzyme-catalysed reaction was studied in the absence ($-\text{I}$) and presence ($+\text{I}$) of a reversible competitive inhibitor. Double-reciprocal analysis of the kinetic data yielded the following linear regression equations:

• Absence of Inhibitor ($-\text{I}$): $y = 0.5x + 0.1$
• Presence of $3.0\ \text{mM}$ Inhibitor ($+\text{I}$): $y = 1.0x + 0.1$

Calculate the values of:

1. $\text{V}_{\text{max}}$
2. The apparent $K_{\text{m}}$ in the presence of the inhibitor.
3. The inhibition dissociation constant ($K_{\text{i}}$) for the enzyme-inhibitor complex.

Solution:

The Lineweaver-Burk equation is:

$$ \frac{1}{\text{V}_0} = \left(\frac{K_{\text{m}}}{\text{V}_{\text{max}}}\right)\frac{1}{[\text{S}]} + \frac{1}{\text{V}_{\text{max}}} $$

Calculate $\text{V}_{\text{max}}$: The $y$-intercept ($c$) is equal to $1/\text{V}_{\text{max}}$. From both equations, the $y$-intercept is $0.1$:

$$ \frac{1}{\text{V}_{\text{max}}} = 0.1 \implies \text{V}_{\text{max}} = \frac{1}{0.1} = 10\ \mu\text{M/min} $$

The maximum velocity is $10\ \mu\text{M/min}$.

Calculate the Apparent $K_{\text{m}}$ ($K_{\text{m,app}}$):

• In the absence of inhibitor, the slope ($m$) is $0.5$:
  $$ \text{Slope} = \frac{K_{\text{m}}}{\text{V}_{\text{max}}} = 0.5 \implies K_{\text{m}} = 0.5 \times \text{V}_{\text{max}} = 0.5 \times 10 = 5\ \text{mM} $$
• In the presence of the competitive inhibitor, the apparent slope is $1.0$:
  $$ \text{Slope}_{\text{app}} = \frac{K_{\text{m,app}}}{\text{V}_{\text{max}}} = 1.0 \implies K_{\text{m,app}} = 1.0 \times \text{V}_{\text{max}} = 1.0 \times 10 = 10\ \text{mM} $$

The apparent $K_{\text{m}}$ in the presence of the inhibitor is $10\ \text{mM}$ (representing a twofold increase).

Calculate the Inhibition Dissociation Constant ($K_{\text{i}}$): For a competitive inhibitor, the apparent $K_{\text{m}}$ is increased by the alpha factor ($\alpha$):

$$ K_{\text{m,app}} = \alpha K_{\text{m}} $$

Substitute the calculated values into the equation:

$$ 10 = \alpha \times 5 \implies \alpha = 2 $$

The expression for the alpha factor is:

$$ \alpha = 1 + \frac{[\text{I}]}{K_{\text{i}}} $$

Substitute $\alpha = 2$ and $[\text{I}] = 3.0\ \text{mM}$ into the equation:

$$ 2 = 1 + \frac{3.0}{K_{\text{i}}} \implies 1 = \frac{3.0}{K_{\text{i}}} \implies K_{\text{i}} = 3.0\ \text{mM} $$

The inhibition dissociation constant ($K_{\text{i}}$) of the enzyme for this inhibitor is exactly $3.0\ \text{mM}$.